KING OF PRUSSIA, PA / ACCESSWIRE / June 24, 2019 / Emergent Health Corp. (the “Company”) (OTC PINK: EMGE) purpose of this Press Release is to bring shareholders to date:
The Company hopes shareholders will find this Press Release informative as to its intentions.
About Emergent Health Corp.
Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. With patented, patent pending and proprietary nutritionally designed products, Emergent believes it is positioning itself as a leader in the fields of Regenerative Medicine and/or Health as defined by the National Institute of Health.
This press release contains certain “forward-looking” statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors that could cause actual results to differ materially from those estimated by the company.
This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.
CONTACT:
Emergent Health Corp.
Investor Relations
484-518-9000
SOURCE: Emergent Health Corp.
View source version on accesswire.com:
https://www.accesswire.com/549500/Emergent-Health-Corp-EMGE-OTC-Markets-Further-Progress-Report
FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…
PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…
Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…
TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…
SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…